Page 687

(3) erythromycin ophthalmic ointment;

(4) a department-approved alternative prophylactic ophthalmic agent as recommended by the Centers for Disease Control and Prevention for the prevention of ophthalmia neonatorum in the newborn. (b) Prophylaxis is not required

(1) if the infant is receiving parenteral antibiotics; or

(2) if the infant’s delivery occurs at an unplanned time when prophylactic measures are unavailable. (c) A physician, nurse, or certified direct-entry midwife who detects gonorrhea infection of the eye in a newborn infant shall report the infant’s name, birth date, extent of infection, and place of residence to the Section of Epidemiology within the department. (Eff. 5/3/80, Register 74; am 1/17/2008, Register 185; am 9/18/2009, Register 192) Statutory Authority: Authority: AS 18.05.040 Editor’s note: Information about the department-approved alternative prophylactic ophthalmic agents referred to in 7 AAC 27.111(a) may be obtained from the Department of Health, Division of Public Health, Section of Women’s, Children’s and Family Health, 3601 C Street, Ste. 756, Anchorage, Alaska 99503; Phone: (907) 269-3400; Internet address: http://www.hss.state.ak.us/dph/. Article 4. Statewide Immunization Program. Rule 7 AAC 27.115. Assessable entity or other program participant reporting and payment 7 AAC 27.120. Method for reducing surplus payments 7 AAC 27.125. State Vaccine Assessment Council 7 AAC 27.130. Plan of operation 7 AAC 27.135. Appeals 7 AAC 27.140. Opt-in procedure for other program participants 7 AAC 27.145. Request for information; noncompliance fee 7 AAC 27.149. Definitions 7 AAC 27.115. Assessable entity or other program participant reporting and payment.